ISAAC ROSENBLUM: Open Payments
NPI 1154709624 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,030 in 231 payments from 18 companies in 2025. Trend: 2023 $2,658 · 2024 $4,514 · 2025 $5,030
Food & beverage: $4,942Education: $88
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 50 | $797 |
| ABBVIE INC. | 27 | $596 |
| Galderma Laboratories, L.P. | 19 | $491 |
| LEO Pharma Inc. | 22 | $449 |
| Arcutis Biotherapeutics, Inc. | 9 | $358 |
| Janssen Biotech, Inc. | 6 | $349 |
| Organon LLC | 16 | $340 |
| Lilly USA, LLC | 11 | $259 |
| E.R. Squibb & Sons, L.L.C. | 27 | $250 |
| Botanix SB Inc | 7 | $232 |
Products named: OPZELURA, NEMLUVIO, ADBRY, Zoryve, SKYRIZI, TREMFYA, Sotyktu, RINVOQ.
Industry payments across NY — which companies pay providers there.
